Rating Rationale
July 28, 2021 | Mumbai
UPL Limited
Rating outlook revised to 'Stable'; NCD withdrawn
 
Rating Action
Total Bank Loan Facilities RatedRs.4000 Crore
Long Term RatingCRISIL AA+/Stable (Outlook revised from 'Negative'; Rating reaffirmed)
Short Term RatingCRISIL A1+ (Reaffirmed)
 
Rs.500 Crore Non Convertible DebenturesCRISIL AA+/Stable (Outlook revised from 'Negative'; Rating withdrawn)
Rs.1500 Crore (Enhanced from Rs.1350 Crore) Commercial PaperCRISIL A1+ (Reaffirmed)
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL Ratings has revised its outlook on the long term rating of UPL Ltd (UPL) to ‘Stable’ from ‘Negative’ and reaffirmed the rating at ‘CRISIL AA+’. The ratings on the company’s short term debt and commercial paper programme have been reaffirmed at ‘CRISIL A1+’. The rating on the non-convertible debentures programme has been withdrawn on company’s request. The withdrawal is in line with CRISIL Ratings’ withdrawal policy..

 

The outlook revision follows CRISIL Ratings expectations that UPL’s debt metrics will continue improving over the medium term, supported by steady demand prospects for agrochemicals, healthy profitability, and sizeable cash generation, besides moderate capital spending. In fiscal 2021, debt metrics improved to better than anticipated levels, supported by strong cash flows from operations, steady working-capital management and progressive debt reduction. The company’s gross debt (~Rs.26000 crore at March 31, 2021) reduced by ~Rs. 4800 crore, compared with fiscal 2020 levels, which was higher than expected, backed by healthy cash generation. Hence, debt metrics such as interest cover and net debt / earnings before interest, tax, depreciation, and amortization (EBITDA) improved to 4.30 times and 2.47 times respectively in fiscal 2021, from 3.98 times and 3.39 times in fiscal 2020.

 

UPL registered a strong operating performance in fiscal 2021, supported by strong growth across geographies; revenue grew by a healthy 8% year on year. Favourable product mix, cost synergies and cost-optimization measures benefitted operating margins, which improved 220 basis points to 22.1%. Supported by company’s healthy business risk profile, strong R&D pipeline, and healthy presence in large markets like Latin America (LATAM), revenue growth should remain in high single digits over the medium term. Profitability should benefit from introduction of higher margin bio-solutions as well as improving cost efficiencies. Operating margin should remain healthy at ~over 20%.

 

The ratings continue to reflect UPL’s strong business risk profile supported by a strong market position, geographical diversification in revenue, and healthy profitability backed by sound operating efficiencies, leading to sizeable annual cash generation. Financial risk profile is expected to remain adequate and debt metrics improve gradually over the medium term, with increased integration benefits from the acquisition of Arysta. These strengths are partially offset by large working capital requirement and susceptibility to risks inherent in the agrochemical sector.

Analytical Approach

To arrive at its ratings, CRISIL Ratings has combined the business and financial risk profiles of UPL Ltd and its subsidiaries, collectively known as UPL. This is because all these companies are under a common management and have close operational linkages and fungible cash flows. CRISIL Ratings follows a moderate integration approach for investment in associates and joint ventures in which UPL has significant influence but not a controlling interest - specifically, CRISIL Ratings factors in UPL's share in the profit of these entities and any incremental investment required.

 

Goodwill on the acquisition of Arysta is being amortised over a period of 15 years commencing from fiscal 2019. Consequently, reported PAT, net worth, and ratio computations are adjusted.

 

USD denominated Perpetual Subordinated Capital Securities (Bonds) of USD 400 Million (interest coupon rate of 5.25% p.a.) raised by UPL Corporation Ltd (subsidiary of UPL) has been treated as 50% debt and 50% equity.

 

Please refer Annexure - List of entities consolidated, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths

  • Large scale with diverse geographical presence and wide product portfolio: UPL is among the top 5 players in the global agrochemicals industry. Revenue base is well diversified, with ~70% generated from LATAM, Europe, and the US in fiscal 2021. Wider geographical reach reduces susceptibility to cyclicality in demand from any one region. The company is also present across the crop lifecycle, from seeds, seed-treatment products, pre- and post-harvest products, to storage-treatment products. Business risk profile remains healthy, aided by a portfolio of 13,000+ registrations, over 200 active ingredients, and 1,023 patents. The group is present in 138 countries with 48 manufacturing locations, employing more than 10,400 people across the globe.

 

  • Sound operating efficiencies, supporting healthy profitability: Backward integration and supply-chain management have strengthened operating efficiencies. As a sizeable portion of raw material and power requirement is met in-house, the group is assured a steady supply, with lesser price volatility. Flexible and multi-product manufacturing facilities, and the robust supply chain and distribution network have kept operating margin.

 

Synergistic cost savings of about USD 200 million in fiscal 2021 on account of acquisition due to better backward integration, personnel and non-personnel cost savings, and various other geographical and logistical cost benefit also resulted in significant cost saving for the combined entity, leading to operating profitability of over 22% in fiscal 2021 against 19.9% in fiscal 2020. CRISIL Ratings expects UPL will continue to maintain healthy operating profitability of over 20% over the medium term, supported by its strong efficiencies, and as it aims to enhance the share of high margin differentiated products from ~30% in fiscal 2021.

 

  • Improving financial risk profile: The acquisition of Arysta in fiscal 2019 was funded through substantial debt (~USD 3 billion), which resulted in moderation in debt metrics. However, the company has been reducing its debt over the last 2 years which has led to gradual improvement in financial risk profile. In fiscal 2021, the company reduced its gross debt by ~Rs. 4800 crore supported by strong operational cash generation and partial pre-payment of debt. UPL’s financial risk profile is also supported by sizeable adjusted net worth of Rs 22,500 crore estimated as on March 31, 2021.

 

UPL’s management is committed to reducing debt levels further over the medium term. Along with strong operating performance and continuing healthy cash flow generating ability, net debt to EBITDA is expected to reduce to below 2.3 times in fiscal 2022 and below 2.00 times in fiscal 2023. Any sizeable debt funded acquisition will remain a credit monitorable.

 

The lock-in period for UPL Corp's minority investors, Abu Dhabi Investment Authority and TPG Capital Asia, each with ~11% stake, and who had invested in UPL Corp to support the acquisition of Arysta, expires in July 2021. These investors have the option to sell their stakes to UPL, which has right of first refusal, or to any other external parties. While the stake sale is unlikely in next 1-2 years, any material debt addition by UPL to buy back these stakes in UPL Corp from these investors, and consequent increase in its leverage will be another key credit monitorable.

 

Weaknesses

  • Large working capital requirement: The crop protection business is seasonal in nature. Sales occur at the start of the season, but payment is realised post-harvest, resulting in long receivable cycle. Furthermore, as goods are manufactured at one place and distributed to other locations, sizeable stock of finished goods needs to be maintained. The large credit required by customers in key LATAM markets also leads to a stretch in working capital cycle. However, the group will contain the exposure to markets with long credit cycle to less than one-third of its revenue and utilise securitisation benefits (without recourse) wherever available, thereby mitigating the impact of a stretched cycle on the overall credit profile.

 

  • Susceptibility to risks inherent in the agrochemicals sector: The crop-protection sector remains susceptible to specific and separate registration processes in different countries, and various environmental rules and regulations. Change in regulatory requirements, such as export and import policies and environmental and safety requirements in countries where the company has significant exposure, could weaken growth prospects. Furthermore, the sector is highly dependent on monsoon and level of farm income. Hence, timing and distribution of rainfall during a year plays a crucial role.

Liquidity: Strong

Cash and cash equivalents stood at Rs 4850 crore as on March 31, 2021 (Rs 6,750 crore as on March 31, 2020). Utilisation of domestic fund-based working capital limits was moderate at about 37% (of drawing power) for the 12 months through June 2021. While the company is expected to reduce its cash surpluses and pay down debt over a period of time, liquidity is still expected to remain strong over the medium term, supported by healthy cash generation (in excess of Rs. 5000 crore annually), and notwithstanding large working capital requirements. Annual capital expenditure (capex) of about Rs 2,500 crore is also expected to be funded largely from internal accruals.

 

The company has modest annual repayments of Rs 75 crore and Rs 135 crore in fiscal 2022 and 2023, which can be serviced from annual accruals. However, the debt repayments are sizeable at almost Rs 11000 crore in the fourth quarter of fiscal 2024, and will require part refinancing. Given that the company has been able to arrange large funding in timely manner in the past, CRISIL Ratings expects the company will also be able to refinance required portion of their obligations in fiscal 2024.

Outlook: Stable

CRISIL Ratings believes the UPL group’s business risk profile has improved significantly by the acquisition of Arysta, propelling it to the position of the fifth-largest player in the global agrochemical space and the fourth-largest seed manufacturer. Better scale and business synergies, as well as product mix in favour of higher margin products, are expected to also help improve sustain operating profitability at over 20-22% over the medium term, benefitting cash generation. This along with progressive debt reduction, will help keep debt metrics at comfortable levels over the medium term.

Rating Sensitivity Factors

Upward Factors

  • Sustained healthy growth in revenues, with operating profitability in excess of 20-22%
  • Net Debt/EBITDA remaining below 1-1.25 time on a sustained basis, due to better than anticipated cash generation and lower debt levels due to prudent working capital or equity infusion.

 

Downward Factors

  • Sharp decline in revenue growth and fall in operating profitability to below 16-17%, materially impacting cash generation
  • Further increase in net debt/EBITDA levels beyond 3.0 times in fiscal 2022 and above 2.5 times in fiscal 2023, due to lower cash generation or higher debt levels, due to more than anticipated capex, material acquisitions and elongation in working capital cycle, or to increase stake in UPL Corp.

About the Company

Incorporated in 1969 and promoted by Mr Rajnikant Shroff, UPL manufactures, markets, and distributes crop protection products, intermediates, speciality chemicals, and other industrial chemicals; and undertakes research in these segments. Over time, UPL has made several acquisitions and entered into strategic alliances to diversify product profile and increase geographical reach. The group now includes over 200 entities. Apart from UPL, the other key operating companies in the group are United Phosphorus Inc (US), United Phosphorus Ltd (UK), Cerexagri SAS, Icona SA (Argentina), Decco US Post Harvest Inc, and UPL do Brasil Industria e Comercio de SA (Brazil). The company has manufacturing units in India, France, the Netherlands, Argentina, the UK, Vietnam, Turkey, Brazil, the USA, China, Thailand, Italy, Australia, and Columbia.

Key Financial Indicators

Particulars for year ending March 31

Unit

2021

2020

Revenue

Rs.Crore

38,694

35,756

Adjusted profit after tax (PAT)^

Rs.Crore

2,385

1,064

PAT margin^

%

6.2

3.0

Adjusted debt/Adjusted net worth^

Times

1.16

1.50

 Adjusted interest coverage

Times

4.30

3.98

^CRISIL-adjusted numbers for treatment of goodwill

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL Ratings' complexity levels are assigned to various types of financial instruments. The CRISIL Ratings' complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL Ratings' complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of instrument

Date of allotment

Coupon
rate (%)

Maturity date

Issue
size
(Rs.Crore)

Complexity level

Rating assigned  with outlook

N.A.

Cash credit#

N.A.

N.A.

N.A.

1150

NA

CRISIL AA+/Stable

N.A.

Letter of credit & bank guarantee

N.A.

N.A.

N.A.

650

NA

CRISIL A1+

N.A

Proposed cash credit Limit**

N.A.

N.A.

N.A.

500

NA

CRISIL AA+/Stable

N.A.

Proposed Working capital facility**

N.A.

N.A.

N.A.

1500

NA

CRISIL AA+/Stable

N.A.

Proposed long-term bank loan facility**

N.A.

N.A.

N.A.

200

NA

CRISIL AA+/Stable

N.A.

Commercial paper

N.A.

N.A.

7-365 days

1500

Simple

CRISIL A1+

#Fully interchangeable between cash credit, working capital demand loan, foreign currency non-resident (Bank) loans, packing credit in INR, packing credit in foreign currency, export bill discounting in INR and foreign currency, buyer's credit for imports and domestic purchases, and domestic sales bill discounting. It can also be converted into non-fund-based facilities.

**It can be converted into non-fund-based facilities.

 

Annexure - Details of Rating Withdrawn

ISIN

Name of instrument

Date of allotment

Coupon
rate (%)

Maturity date

Issue
size
(Rs.Crore)

Complexity level

N.A.

Non-convertible debentures*

N.A.

N.A.

N.A.

500

Simple

*Yet to be issued

Annexure – List of entities consolidated

Sr.No

Consolidated entities

Extent of Consolidation

Rationale

1

Shroffs United Chemicals Limited       

Full

Wholly owned subsidiary

2

SWAL Corporation Limited        

Full

Wholly owned subsidiary

3

United Phosphorus (India) LLP       

Full

Subsidiary

4

United Phosphorus Global LLP       

Full

Wholly owned subsidiary

5

Optima Farm Solutions Limited       

Full

Wholly owned subsidiary

6

UPL Europe Limited        

Full

Subsidiary

7

United Phosphorus Polska Sp.z o.o – Poland    

Full

Subsidiary

8

UPL Benelux B.V.        

Full

Subsidiary

9

Cerexagri B.V.         

Full

Subsidiary

10

United Phosphorus Holdings Cooperatief U.A.      

Full

Subsidiary

11

United Phosphorus Holdings B.V.       

Full

Subsidiary

12

Decco Worldwide Post-Harvest Holdings Cooperatief U.A.     

Full

Subsidiary

13

Decco Worldwide Post-Harvest Holdings B.V.      

Full

Subsidiary

14

United Phosphorus Holding, Brazil B.V.      

Full

Subsidiary

15

UPL Italia S.R.L.        

Full

Subsidiary

16

UPL Iberia, S.A.        

Full

Subsidiary

17

Decco Iberica Postcosecha, S.A.U.       

Full

Subsidiary

18

Transterra Invest, S. L. U.      

Full

Subsidiary

19

Cerexagri S.A.S.         

Full

Subsidiary

20

Neo-Fog S.A.         

Full

Subsidiary

21

UPL France         

Full

Subsidiary

22

United Phosphorus Switzerland Limited       

Full

Subsidiary

23

Agrodan, ApS         

Full

Subsidiary

24

Decco Italia SRL        

Full

Subsidiary

25

Limited Liability Company UPL       

Full

Subsidiary

26

Decco Portugal Post Harvest LDA      

Full

Subsidiary

27

UPL NA Inc. (formerly known as United Phosphorus Inc.)  

Full

Subsidiary

28

UPI Finance LLC        

Full

Subsidiary

29

Cerexagri, Inc. (PA)        

Full

Subsidiary

30

UPL Delaware, Inc.        

Full

Subsidiary

31

Canegrass LLC USD        

Full

Subsidiary

32

Decco US Post-Harvest Inc       

Full

Subsidiary

33

Essentiv LCC         

Full

Subsidiary

34

RiceCo LLC         

Full

Subsidiary

35

Riceco International, Inc.        

Full

Subsidiary

36

UPL Corporation Limited        

Full

Subsidiary

37

UPL Management DMCC        

Full

Subsidiary

38

UPL Limited         

Full

Subsidiary

39

UPL Agro S.A. de C.V.      

Full

Subsidiary

40

Decco PostHarvest Mexico (Formerly Known as Decco Jifkins Mexico Sapi) 

Full

Subsidiary

41

Perrey Participações S.A        

Full

Subsidiary

42

Uniphos Industria e Comercio de Produtos Quimicos Ltda.   

Full

Subsidiary

43

UPL Costa Rica S.A.       

Full

Subsidiary

44

UPL Bolivia S.R.L        

Full

Subsidiary

45

UPL Paraguay S.A.        

Full

Subsidiary

46

Icona Sanluis S.A.        

Full

Subsidiary

47

UPL Argentina S A       

Full

Subsidiary

48

Decco Chile SpA        

Full

Subsidiary

49

UPL Colombia SAS        

Full

Subsidiary

50

United Phosphorus Cayman Limited       

Full

Subsidiary

51

UP Aviation Limited        

Full

Subsidiary

52

UPL Australia Limited        

Full

Subsidiary

53

UPL New Zealand Limited       

Full

Subsidiary

54

UPL Shanghai Limited        

Full

Subsidiary

55

UPL Jiangsu Limited        

Full

Subsidiary

56

UPL Limited (Korea)        

Full

Subsidiary

57

PT.UPL Indonesia         

Full

Subsidiary

58

PT Catur Agrodaya Mandiri       

Full

Subsidiary

59

UPL Limited,Hong Kong( Formerly Known as United Phosphorus Limited, Hongkong) 

Full

Subsidiary

60

UPL Philippines Inc.        

Full

Subsidiary

61

UPL Vietnam Co. Limited       

Full

Subsidiary

62

UPL Limited, Japan        

Full

Subsidiary

63

Anning Decco Fine Chemical Co. Limited     

Full

Subsidiary

64

UPL Ziraat Ve Kimya Sanayi Ve Ticaret Limited Sirketi  

Full

Subsidiary

65

UPL Agromed Tarim Ilaclari ve Tohumculuk Sanayi ve Ticaret A.S. 

Full

Subsidiary

66

Safepack Products Limited        

Full

Subsidiary

67

Citrashine (Pty) Ltd        

Full

Subsidiary

68

Prolong Limited         

Full

Subsidiary

69

Agrinet Solutions Limited        

Full

Subsidiary

70

Advanta Holdings B.V.        

Full

Subsidiary

71

Advanta Netherlands Holding B.V.       

Full

Subsidiary

72

Advanta US LLC (formerly known as Advanta U.S. Inc.)  

Full

Subsidiary

73

Advanta Seeds International        

Full

Subsidiary

74

Advanta Seeds         

Full

Subsidiary

75

Advanta Comercio De Sementes LTDA.      

Full

Subsidiary

76

Advanta Semillas         

Full

Subsidiary

77

Advanta Seeds Pty Ltd       

Full

Subsidiary

78

Pacific Seeds (Thai) Limited       

Full

Subsidiary

79

Pacific Seeds Holdings (Thailand) Limited      

Full

Subsidiary

80

PT Advanta Seeds Indonesia       

Full

Subsidiary

81

Advanta Seeds Ukraine LLC       

Full

Subsidiary

82

UPL Limited Mauritius (Formely known as UPL Agro Limited Mauritius) 

Full

Subsidiary

83

Riceco International Bangladesh Ltd       

Full

Subsidiary

84

Uniphos Malaysia Sdn Bhd       

Full

Subsidiary

85

Decco Gida Tarim ve Zirai Ürünler San. Tic A.S.  

Full

Subsidiary

86

Arysta LifeScience Australia Pty Ltd.      

Full

Subsidiary

87

Arysta LifeScience Iberia SLU       

Full

Subsidiary

88

Arysta LifeScience Benelux SPRL       

Full

Subsidiary

89

ANESA S.A.         

Full

Subsidiary

90

Arysta LifeScience (Mauritius) Ltd       

Full

Subsidiary

91

UPL South Africa (Pty) Ltd (FKA Arysta LifeScience South Africa (Pty) Ltd)

Full

Subsidiary

92

Arysta LifeScience Argentina S.A. USD      

Full

Subsidiary

93

Arysta LifeScience Chile S.A.       

Full

Subsidiary

94

Arysta LifeScience Colombia S.A.S       

Full

Subsidiary

95

Arysta LifeScience Mexico, S.A.de C.V      

Full

Subsidiary

96

Grupo Bioquimico Mexicano, S.A. de C.V.     

Full

Subsidiary

97

Arysta LifeScience Costa Rica SA.      

Full

Subsidiary

98

MacDermid (Shanghai) Chemical Ltd. 0.78      

Full

Subsidiary

99

UPL Deutschland GmbH, (formerly known as Arysta LifeScience Germany GmbH) 

Full

Subsidiary

100

UPL Polska Sp. z.o.o ( FKA Arysta LifeScience Polska Sp. z.o.o)

Full

Subsidiary

101

PPWJ Sci         

Full

Subsidiary

102

Arysta LifeScience Japan Holdings Goudou Kaisha     

Full

Subsidiary

103

Arysta LifeScience Cameroun SA       

Full

Subsidiary

104

Arysta LifeScience (Shanghai) Co., Ltd.      

Full

Subsidiary

105

Arysta Health and Nutrition Sciences Corporation     

Full

Subsidiary

106

Arysta LifeScience Corporation        

Full

Subsidiary

107

Arysta LifeScience S.A.S.        

Full

Subsidiary

108

Arysta LifeScience Germany GmbH       

Full

Subsidiary

109

Arysta LifeScience Polska Sp. z.o.o      

Full

Subsidiary

110

Arysta LifeScience Peru S.A.C       

Full

Subsidiary

111

GBM USA LLC        

Full

Subsidiary

112

Arysta LifeScience S.R.L.        

Full

Subsidiary

113

MacDermid Agricultural Solutions Australia Pty Ltd     

Full

Subsidiary

114

Arysta LifeScience Services LLP       

Full

Subsidiary

115

Arysta LifeScience India Limited       

Full

Subsidiary

116

Arysta LifeScience Agriservice Private Limited      

Full

Subsidiary

117

Arysta Agro Private Limited       

Full

Subsidiary

118

Arysta LifeScience Ougrée Production Sprl      

Full

Subsidiary

119

Arysta LifeScience U.K. BRL Limited      

Full

Subsidiary

120

Arysta LifeScience UK & Ireland Ltd     

Full

Subsidiary

121

United Phosphorus Global Services Limited (FKA Arysta LifeScience Global Services Limited)

Full

Subsidiary

122

Arysta LifeScience U.K. JPY Limited      

Full

Subsidiary

123

Arysta LifeScience U.K. Limited       

Full

Subsidiary

124

Arysta Lifescience U.K. Holdings Limited      

Full

Subsidiary

125

Arysta LifeScience Romania SRL       

Full

Subsidiary

126

Arysta LifeScience Global Limited       

Full

Subsidiary

127

Arysta LifeScience U.K. CAD Limited      

Full

Subsidiary

128

Arysta LifeScience European Investments Limited      

Full

Subsidiary

129

Arysta LifeScience Great Britain Ltd      

Full

Subsidiary

130

Arysta LifeScience U.K. USD Limited      

Full

Subsidiary

131

Arysta LifeScience U.K. EUR Limited      

Full

Subsidiary

132

Arysta LifeScience Netherlands BV       

Full

Subsidiary

133

UPL Agricultural Solutions Holdings BV (FKA MacDermid Agricultural Solutions Holdings BV)

Full

Subsidiary

134

UPL Agricultural Solutions Netherlands BV      

Full

Subsidiary

135

Arysta LifeScience Technology BV       

Full

Subsidiary

136

UPL Agricultural Solutions (FKA MacDermid Agricultural Solutions Italy Srl)  

Full

Subsidiary

137

Arysta LifeScience Bulgaria EOOD       

Full

Subsidiary

138

Vetopharma Iberica SL (FKA Santamix Iberica SL,Spain)    

Full

Subsidiary

139

Platform Sales Suisse GmbH       

Full

Subsidiary

140

Natural Plant Protection S.A.S.       

Full

Subsidiary

141

Arysta LifeScience Holdings France SAS      

Full

Subsidiary

142

Laboratoires Goëmar SAS        

Full

Subsidiary

143

Vetophama SAS (FKA Arysta Animal Health SAS)    

Full

Subsidiary

144

Betel Reunion S.A.        

Full

Subsidiary

145

Arysta LifeScience Czech s.r.o.       

Full

Subsidiary

146

UPL Agrosolutions Canada Inc (fka Arysta LifeScience Canada, Inc.)  

Full

Subsidiary

147

Arysta LifeScience Vostok Ltd.       

Full

Subsidiary

148

Arysta LifeScience RUS LLC       

Full

Subsidiary

149

Arysta LifeScience Slovakia S.R.O.       

Full

Subsidiary

150

Arysta LifeScience Ukraine LLC       

Full

Subsidiary

151

Arysta LifeScience Kiev LLC       

Full

Subsidiary

152

Arysta LifeScience Inc.        

Full

Subsidiary

153

Arysta LifeScience Management Company, LLC      

Full

Subsidiary

154

Arysta LifeScience SPC, LLC       

Full

Subsidiary

155

Arysta LifeScience America Inc.       

Full

Subsidiary

156

UPL Agrosolutions Canada Inc (fka Arysta LifeScience Canada, Inc.)  

Full

Subsidiary

157

Arysta LifeScience Canada BC Inc.      

Full

Subsidiary

158

Arysta LifeScience North America, LLC      

Full

Subsidiary

159

Arysta LifeScience NA Holding LLC      

Full

Subsidiary

160

Dutch Agricultural Investment Partners LLC      

Full

Subsidiary

161

Netherlands Agricultural Investment Partners LLC      

Full

Subsidiary

162

Arysta LifeScience Investments LLC       

Full

Subsidiary

163

Arysta LifeScience Mexico Holding S.A.de C.V     

Full

Subsidiary

164

Bioenzymas S.A. de C.V.       

Full

Subsidiary

165

Desarrollos Inmobiliarios Alianza de Coahuila, S.A. de C.V.   

Full

Subsidiary

166

Agroquimicos y Semillas, S.A. de C.V.     

Full

Subsidiary

167

Omega Agroindustrial, S.A. de C.V.      

Full

Subsidiary

168

Servicios Agricolas Mundiales SA de CV     

Full

Subsidiary

169

Tecno Extractos Vegetales, S.A. de C.V.     

Full

Subsidiary

170

Tesaurus Mexico S.A. de C.V.      

Full

Subsidiary

171

Arysta LifeScience de Guatemala, S.A.      

Full

Subsidiary

172

Arysta LifeScience Paraguay S.R.L.       

Full

Subsidiary

173

Etec Crop Solutions Limited       

Full

Subsidiary

174

Arysta LifeScience Korea Ltd.       

Full

Subsidiary

175

Arysta LifeScience Pakistan (Pvt.) LTD.      

Full

Subsidiary

176

Myanmar Arysta LifeScience Co., Ltd.      

Full

Subsidiary

177

Arysta LifeScience (Thailand) Co., Ltd.      

Full

Subsidiary

178

Chemtura (Thailand) Ltd        

Full

Subsidiary

179

Pt. Arysta LifeScience Tirta Indonesia      

Full

Subsidiary

180

Arysta LifeScience Philippines Inc.       

Full

Subsidiary

181

Arysta LifeScience Vietnam Co., Ltd.      

Full

Subsidiary

182

Arysta LifeScience Asia Pte., Ltd.      

Full

Subsidiary

183

Arysta LifeScience Turkey Tarim Urunleri Limited Sirketi    

Full

Subsidiary

184

Agrifocus Limitada         

Full

Subsidiary

185

Anchorprops 39 (Pty) Ltd       

Full

Subsidiary

186

Arysta LifeScience Holdings SA (Pty) Ltd     

Full

Subsidiary

187

Callietha Investments (Pty) Ltd       

Full

Subsidiary

188

Volcano Agroscience (Pty) Ltd       

Full

Subsidiary

189

Volcano Chemicals (Pty) Ltd       

Full

Subsidiary

190

Sidewalk Trading (Pty) Ltd       

Full

Subsidiary

191

Arysta LifeScience Kenya Ltd.       

Full

Subsidiary

192

Arysta LifeScience Tanzania Ltd       

Full

Subsidiary

193

Arysta LifeScience Egypt Ltd       

Full

Subsidiary

194

UPL Togo SAU (FKA Arysta LifeScience Togo SAU)   

Full

Subsidiary

195

Calli Ghana Ltd.        

Full

Subsidiary

196

Callivoire SGFD S.A.        

Full

Subsidiary

197

Mali Protection Des Cultures (M.P.C.) SA     

Full

Subsidiary

198

Agriphar Poland Sp. Zoo       

Full

Subsidiary

199

Arysta LifeScience Switzerland Sarl       

Full

Subsidiary

200

Arysta LifeScience CentroAmerica, S.A.       

Full

Subsidiary

201

Arvesta Corporation         

Full

Subsidiary

202

Arysta LifeScience Registrations Great Britain Ltd     

Full

Subsidiary

203

Agriphar SDN BHD        

Full

Subsidiary

204

Industrias Agriphar SA        

Full

Subsidiary

205

Agripraza Ltda.         

Full

Subsidiary

206

Arysta LifeScience Corporation Republica Dominicana, SRL     

Full

Subsidiary

207

Grupo Bioquimico Mexicano Republica Dominicana SA     

Full

Subsidiary

208

Upl do Brasil Industria e Comércio de Insumos Agropecuários S.A. 

Full

Subsidiary

209

Arvesta Paraguay S.A.        

Full

Subsidiary

210

Arysta Agroquimicos y Fertilzantes Uruguay SA     

Full

Subsidiary

211

Arysta LifeScience U.K. USD-2 Limited      

Full

Subsidiary

212

Industrias Bioquim Centroamericana, Sociedad Anónima      

Full

Subsidiary

213

Procultivos, Sociedad Anónim        

Full

Subsidiary

214

Inversiones Lapislazuli Marino, Sociedad Anónima      

Full

Subsidiary

215

Bioquim, Sociedad Anónima        

Full

Subsidiary

216

Bioquim Panama, Sociedad Anónima       

Full

Subsidiary

217

Bionic Nicaragua, Sociedad Anónima       

Full

Subsidiary

218

Biochemisch Dominicana, Sociedad De Responsabilidad Limitada     

Full

Subsidiary

219

Nutriquim De Guatemala, Sociedad Anónima      

Full

Subsidiary

220

UPL Agro Ltd        

Full

Subsidiary

221

UPL Portugal Unipessoal, Ltda.       

Full

Subsidiary

222

UPL Services LLC        

Full

Subsidiary

223

United Phosphorus Holdings Uk Ltd      

Full

Subsidiary

224

AFS Agtech Pvt. Limited       

Full

Wholly owned subsidiary

225

Natural Plant Protection Limited       

Full

Wholly owned subsidiary

Annexure - Rating History for last 3 Years
  Current 2021 (History) 2020  2019  2018  Start of 2018
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities LT 3350.0 CRISIL AA+/Stable   -- 10-07-20 CRISIL AA+/Negative 30-12-19 CRISIL AA+/Negative 22-10-18 CRISIL AA+/Watch Negative CRISIL AA+/Stable
      --   --   -- 09-09-19 CRISIL AA+/Negative 24-07-18 CRISIL AA+/Watch Negative --
      --   --   -- 02-01-19 CRISIL AA+/Negative   -- --
Non-Fund Based Facilities ST 650.0 CRISIL A1+   -- 10-07-20 CRISIL A1+ 30-12-19 CRISIL A1+ 22-10-18 CRISIL A1+ CRISIL A1+
      --   --   -- 09-09-19 CRISIL A1+ 24-07-18 CRISIL A1+ --
      --   --   -- 02-01-19 CRISIL A1+   -- --
Commercial Paper ST 1500.0 CRISIL A1+   -- 10-07-20 CRISIL A1+ 30-12-19 CRISIL A1+ 22-10-18 CRISIL A1+ CRISIL A1+
      --   --   -- 09-09-19 CRISIL A1+ 24-07-18 CRISIL A1+ --
      --   --   -- 02-01-19 CRISIL A1+   -- --
Non Convertible Debentures LT 500.0 Withdrawn   -- 10-07-20 CRISIL AA+/Negative 30-12-19 CRISIL AA+/Negative 22-10-18 CRISIL AA+/Watch Negative CRISIL AA+/Stable
      --   --   -- 09-09-19 CRISIL AA+/Negative 24-07-18 CRISIL AA+/Watch Negative --
      --   --   -- 02-01-19 CRISIL AA+/Negative   -- --
All amounts are in Rs.Cr.
 
 
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Cash Credit# 1150 CRISIL AA+/Stable Cash Credit# 1150 CRISIL AA+/Negative
Letter of credit & Bank Guarantee 650 CRISIL A1+ Letter of credit & Bank Guarantee 650 CRISIL A1+
Proposed Cash Credit Limit** 500 CRISIL AA+/Stable Proposed Cash Credit Limit 500 CRISIL AA+/Negative
Proposed Long Term Bank Loan Facility** 200 CRISIL AA+/Stable Proposed Long Term Bank Loan Facility** 200 CRISIL AA+/Negative
Proposed Working Capital Facility** 1500 CRISIL AA+/Stable Proposed Working Capital Facility** 1500 CRISIL AA+/Negative
Total 4000 - Total 4000 -

#Fully interchangeable between cash credit, working capital demand loan, foreign currency non-resident (Bank) loans, packing credit in INR, packing credit in foreign currency, export bill discounting in INR and foreign currency, buyer's credit for imports and domestic purchases, and domestic sales bill discounting. It can also be converted into non-fund-based facilities.

**It can be converted into non-fund-based facilities.

.
Criteria Details
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating Criteria for Chemical Industry
CRISILs Criteria for rating short term debt
CRISILs Criteria for Consolidation

Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
 naireen.ahmed@crisil.com

Anuj Sethi
Senior Director
CRISIL Ratings Limited
B:+91 44 6656 3100
anuj.sethi@crisil.com


Rajeswari Karthigeyan
Associate Director
CRISIL Ratings Limited
D:+91 44 6656 3139
rajeswari.karthigeyan@crisil.com


Biswa Prakash Sukla
Manager
CRISIL Ratings Limited
B:+91 22 3342 3000
Biswa.Sukla@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL Ratings. However, CRISIL Ratings alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Ratings Limited (A subsidiary of CRISIL Limited)

CRISIL Ratings pioneered the concept of credit rating in India in 1987. With a tradition of independence, analytical rigour and innovation, we set the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 33,000 large and mid-scale corporates and financial institutions. We have also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and infrastructure investment trusts (InvITs).
 
CRISIL Ratings Limited ("CRISIL Ratings") is a wholly-owned subsidiary of CRISIL Limited ("CRISIL"). CRISIL Ratings Limited is registered in India as a credit rating agency with the Securities and Exchange Board of India ("SEBI").
 
For more information, visit www.crisilratings.com 




About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide


For more information, visit www.crisil.com

Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


CRISIL PRIVACY NOTICE
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale (each a "Report") that is provided by CRISIL Ratings Limited  (hereinafter referred to as "CRISIL Ratings") . For the avoidance of doubt, the term "Report" includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL Ratings providing or intending to provide any services in jurisdictions where CRISIL Ratings does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL Ratings and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Ratings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL Ratings assumes no obligation to update its opinions following publication in any form or format although CRISIL Ratings may disseminate its opinions and analysis. Rating by CRISIL Ratings contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way. CRISIL Ratings or its associates may have other commercial transactions with the company/entity.

Neither CRISIL Ratings nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, "CRISIL Ratings Parties") guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Ratings Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL RATINGS' PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Ratings Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL Rating's public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee - more details about ratings by CRISIL Ratings are available here: www.crisilratings.com.

CRISIL Ratings and its affiliates do not act as a fiduciary. While CRISIL Ratings has obtained information from sources it believes to be reliable, CRISIL Ratings does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL Ratings has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL Ratings has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: http://www.crisil.com/ratings/highlightedpolicy.html

Rating criteria by CRISIL Ratings are generally available without charge to the public on the CRISIL Ratings public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL Ratings you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL Ratings.

All rights reserved @ CRISIL Ratings Limited. CRISIL Ratings Limited is a wholly owned subsidiary of CRISIL Limited.

CRISIL Ratings uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011 to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL Ratiings' use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: www.crisil.com/ratings/credit-rating-scale.html